PHASE II Market Intelligence recently mapped and profiled 21 European CLL Centers of Excellence on behalf of a life sciences client..
The goal was to identify the top 20 European trial centers of excellence across European countries. Key criteria used to profile the centers included: Hospital Type e.g. International, National or Regional?; Hematology Specialty? Principle Investigators?; All contact detail – hospital and PIs; No. of patients treated by indication; Phase 1 facilities? No. of client IITs; Participation in client clinical trials?; Participation in competitor trials? Etc.
Contact us for further information on our approach to delivering market intelligence
